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| Clinical finding and physical examination
On examination, he was afebrile with a normal blood pressure measuring 125/80 mm Hg and heart rate of 80 beats/ min. Physical examination supports the diagnosis of hepatic encephalopathy.
Hepatic presentation
After admission, he developed hepatic encephalopathy and cirrhosis with abnormal liver function.
Neurologic presentation
After admission, patient was conscious and well oriented.
Ophthalmic presentation
The patient had normal ocular results without Kayser-Fleischer rings (KF rings).
Psychiatric presentation
His neurologic status was unremarkable.
Other organs
Kidney function tests were normal. Central nervous system examination showed normal higher mental functions.
| Laboratory findings
Laboratory studies revealed abnormal liver function, including an elevated serum total bilirubin (T-Bil) level of 2.06 mg/dL Also, low level of ammonia (128 µg/dL) was detected (LLN: 130, ULN: 145 µg/dL). The patient tested negative for hepatitis B virus (HBV) by TaqMan real-time PCR. Antinuclear antibody (ANA) was 5 U/mL (LLN: 10 U/mL) when measured with immunochemiluminescenc procedure, and HCV Ab test was negative.
| Imaging diagnosis

| Ultrasonography
Ultrasonography of the abdomen revealed features suggestive of chronic liver disease and splenomegaly (longitudinal diameter 179 mm). The gallbladder was not visualized due to previous cholecystectomy. Normal size of portal vein diameter and common bile duct (CBD detected, respectively, 11 and 4 mm (Figures 1 and 2 ). The present case had no history of severe cirrhotic change before admission to hospital.
| Endoscopic examination
Endoscopic examination showed 2-3 rows varices at the distal esophagus and proximal lesser curvature ( Figure 3 ).
| Pathological diagnosis
| Liver biopsy and histological examination
Liver biopsy revealed cirrhotic change with moderate to severe steatosis, portal inflammation, liver cell degeneration and necrosis, and glycogenation of periportal hepatocytic nuclei.
Masson's trichrome stain revealed the collagenous fibers surrounding nodules of hepatocytes.
For liver copper concentration detection, liver sample was obtained by needle biopsy. The liver copper concentration in the present case was 1016 mcg/g dry weight liver when measured by neutron activation analysis.
| Transient elastography (fibroscan) assessment
Background patient liver parenchyma showed heterogeneously fibrotic from 19 to 45 kilopascals (kPa). The median fibrosis was 35.5 kPa (equal to F4 based on a Metavir histological index).
The controlled attenuation parameter (CAP) score for liver steatosis was 211 db/m (Figure 4 ).
| Differential diagnosis
The liver of the patient showed chronic liver disease symptoms in which another cause has not been established. Therefore, the diagnosis of WD was considered.
| Treatment
After diagnosis of WD, the patient was prescribed Pantazol (40 mg/d), Amilodipin (5 mg/d), and zinc sulfate (150 mg/d) on day 9 of hospitalization. During the treatment, the diet of the patient was restricted to low-copper, high-calorie, and low-protein meals.
| Follow-up and outcome
After treatment, central nervous system examination showed normal higher mental functions. Other systemic examination was normal. Hepatic copper measurement showed decreased hepatic copper concentration. The use of zinc significantly improved the majority of clinical symptoms of WD. The patients completely responded to the therapy, at the end of the follow-up.
| DISCUSSION
WD is a rare autosomal recessive disorder of copper transport. The excessive deposition of copper due to decreased transport into bile thereby leads to liver damage. The onset of Wilson disease at <40 years of age is rare. We report a unique case of late-onset WD in older patient with typical biochemical markers and absence of typical ocular findings.
In the present case, a fourfold increase of liver copper concentration is considered as the best available test for diagnosis of WD. The accuracy of the test was assessed by other assessments. In literature, a copper content of liver more than 250 mcg/g dry weight is considered diagnostic for WD. 5 The liver has potential to store excess copper in younger individuals than adults. 6 In the recent years, the use of FibroScan to assess liver fibrosis in WD Patients is becoming more widespread. In the literature, a value higher than 8.4 kPa is indicative of severe fibrosis. In the present case, a fourfold increase of the value was considered as the best available test for diagnosis of chronic liver disease. 7 Therefore, FibroScan values can be clinically useful for predicting fibrosis stages of WD patients. 8 In the present case, presence of esophageal varices correlated significantly with the other signs of WD. Esophageal varices are one of a serious consequences of portal hypertension, which usually have no signs and symptoms until bleeding. Loss of consciousness is one of the most signs and symptoms of esophageal varices bleeding. 7, 9, 10 In the present case report, ceruloplasmin level was 221.9 mg/L (in the normal range). Previous studies indicated that, in patients with hepatic WD, plasma ceruloplasmin is often in the normal range. 2 While typically the diagnosis of WD is based on the presence of ophthalmological findings, low level of ceruloplasmin and elevated urinary copper excretion, it is a rare event for WD to have onset in geriatric age. However, in the present case, with elevated urinary copper excretion and hepatic copper deposition, ceruloplasmin and ophthalmological finding were normal. Also, previous cases showed that common neurologic symptoms of WD appear and progress with time.
But in the present case central nervous system examination was completely normal.
The approach to treatment of WD depends on clinical presentation at diagnosis and remains controversial. The current approach includes (a) chelators (D-penicillamine and trientine) for the excretion of copper from the body and (b) zinc salts to reduce copper absorption. 11 In the present case, Zinc sulfate administration (150 mg/d) decreased the majority of clinical symptoms. Previous studies revealed that Zinc sulfate administration is effective in WD patients with mild liver disease. 12 Studies conducted on WD patients indicated that the Zinc sulfate administration is safe and inexpensive. 13 In the present case, the normalization of liver enzymes was observed after zinc therapy. 12 
| CONCLUSIONS
Typically, the diagnosis of WD is based on the presence of ophthalmological findings, low level of ceruloplasmin and elevated urinary copper excretion. But in some case of WD ophthalmological finding can be normal. The result from this case is in consistent with previous studies that in patients with hepatic findings, WD should remain a diagnostic possibility.
